Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 71 Neoplasms 28 Neoplasm Metastasis 15 Colorectal Neoplasms 9 Multiple Myeloma 6 Thyroid Neoplasms 5 Skin Neoplasms 5 Lymphoma, Non-Hodgkin 5 Carcinoma, Non-Small-Cell Lung 5 Thyroid Cancer, Papillary 4 Leukemia, Hairy Cell 4 Hematologic Neoplasms 4 Sarcoma 3 Pancreatic Neoplasms 3 Glioma 3 Breast Neoplasms 3 Wilms Tumor 2 Thyroid Carcinoma, Anaplastic 2 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Rhabdoid Tumor 2 Recurrence 2 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Osteosarcoma 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neuroblastoma 2 Neoplasms by Site 2 Neoplasms by Histologic Type 2 Lymphoma 2

Interventions

Cyclophosphamide 4 Topotecan 3 Ifosfamide 3 Doxorubicin 3 seclidemstat 2 pazopanib 2 Biopsy 2 tebentafusp 1 selinexor 1 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1 fludarabine phosphate 1 fludarabine 1 dostarlimab 1 devimistat 1 cobimetinib 1 cabozantinib 1 atezolizumab 1 Zoledronic Acid 1 X-Rays 1 Vemurafenib 1 Sunitinib 1 Specimen Handling 1 Sirolimus 1 Simvastatin 1 Radiotherapy, Image-Guided 1 Radiotherapy 1 Radiation Dose Hypofractionation 1 Radiation 1 Proton Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma, Clear Cell × Vemurafenib × Clear all

NCT02968303 2020-06-05

COWBOY

Radboud University Medical Center

Phase 2 Unknown

Sarcoma, Clear Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡